Wenzhou Medical University and collaborating institutions have identified a population of human neural retinal stem-like ...

A new study suggests that never-seen-before stem cells in the human retina can restore vision in mice with a common eye ...

Base editing corrected a mutation that causes macular degeneration, highlighting the potential of gene therapy to treat ...

Dry age-related macular degeneration (AMD) significantly affects patients' daily activities and quality of life, regardless of visual impairment.

Co-led by new investors aMoon and Luma Group, Bausch + Lomb, Jefferson Life Sciences and others also participated in the funding, which will accelerate the advancement of pipeline precision therapies ...

Vision loss is a growing concern in India, especially macular degeneration - a common eye condition. Once known to be ...

Surrozen (SRZN) announced that the company will focus its Wnt biology expertise and Wnt signal modulation antibody technologies on its ...

Trading in shares of Opthea remains halted in the U.S. and Australia after the clinical-stage biopharmaceutical company said its lead product candidate, sozinibercept, failed in a late-stage study in ...

Opthea Ltd. is considering its options after lead candidate sozinibercept (OPT-302) failed the phase III Coast trial in wet age-related macular degeneration (AMD). The global Coast phase III trial ...

The Eylea franchise was in need of a win after an appellate court last week denied the pharma’s bid to block Amgen’s ...

A New Jersey-based biotech is looking to become the main character in the age-related macular degeneration field. | A New Jersey-based biotech is looking to become the main character in the ...